C

Celldex Tech Stack

Clinical-stage immunology company developing antibody therapeutics for inflammatory diseases

Biotechnology Research Hampton, NJ 51–200 employees Public Company

Celldex is a public biotech firm focused on antibody-based immunotherapies for allergic, inflammatory, and autoimmune conditions. The hiring mix—heavily weighted toward director and senior roles, with leadership gaps in medical affairs, pricing, and quality—reflects a company scaling commercial and regulatory operations around an active product launch (barzolvolimab). Pain points cluster around inspection readiness, compliance infrastructure, and quality-system scalability, signaling the operational complexity of moving a therapeutic from clinic to market.

Tech Stack 12 technologies

Core StackSAS Python Word Excel Outlook Teams SQL R EndNote PowerPoint Microsoft Office SharePoint

What Celldex Is Building

◆Challenges

Inspection readiness
Compliance with global regulations
Value evidence alignment
Risk-based qa assessments
Managing safety surveillance infrastructure
Audit readiness
Quality system scalability
High-volume scheduling
Scheduling conflicts
Cost-effective supply chain

▲Active Projects

Barzolvolimab global launch
Clinical quality management system improvement
Us field medical affairs strategy development
Kol engagement strategy
Bla submission contributions
Improving safety risk management practices
Medical information contact center
Gcp inspection readiness program
Risk-based qa assessment implementation
Clinical trial recruitment support

Hiring Activity

Accelerating30 roles · 20 in 30d

Department

Healthcare

6

Research

6

Logistics

3

Legal

2

Manufacturing

2

Marketing

2

Operations

2

Data

1

Seniority

Director

14

Senior

10

VP

2

Junior

1

Manager

1

Notable leadership hires: Pricing & Coding Director, Associate Director, Medical Affairs Director

Company intelligence

Find more companies like Celldex by tech stack, pain points and active projects

Get started free

About Celldex

Celldex develops antibody-based treatments targeting inflammatory pathways in allergic and autoimmune disease. The company operates across clinical development, manufacturing, and commercial functions from its New Jersey headquarters. Current operational focus spans regulatory submissions (BLA preparation), clinical trial recruitment, field medical strategy, and launch execution. The organization uses standard enterprise and analytical tools (SQL, SAS, R, Python) typical of biotech ops, with active hiring concentrated in healthcare, research, and logistics roles—infrastructure required for drug approval and commercial readiness.

HeadquartersHampton, NJ

Company Size51–200 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is Celldex working on right now?

Celldex is executing a global launch for barzolvolimab while managing BLA submission, clinical quality systems, and field medical affairs strategy. Key initiatives include KOL engagement, safety surveillance, trial recruitment support, and GCP inspection readiness.

What are Celldex's main operational challenges?

Inspection readiness, global regulatory compliance, quality system scalability, and audit readiness are top pain points. The company is also managing safety surveillance infrastructure and cost-effective supply chain operations.